Fabry disease is an X-linked lysosomal storage disorder. Due to a deficiency of alpha galactosidase A (alpha Gal A) there is adeposition of sphingo lipids within the vascular endothelium. This is associated with vascular dysfunction, alteration in vascular perfusion and a prothromboticstate [1] . Here we report of a 21 year-old male patient with acute or chronic renal failure. Kidney biopsy revealed storage material consistent with Fabry disease. Diagnosis was confirmed by deficient alpha-Gal A-activity. Genetic test in greveiled a previously undescribed homozygous mutation (Exon 5: c.689_697del9pb (p.Ala230_Ile232del) in the GLA gene. The patient started hemodialysis as well as enzyme replacement therapy with a galsidase beta (Fabrazyme; Genzyme).Two months later the patient was admitted to hospital due to an acute of myocardial insufficiency with pericardial effusion. Additionally at admission to the hospital the patient reported of a predominantly left-sided visual impairment.
At ophthalmic exam, best-corrected visual acuity at 1 meter was 20/63 in the right eye and 1/40 in the left eye. The anterior eye segment examination revealed bilateral conjunctival vessel tortuositas in all four quadrants as well as a bilateral grade 1 cornea verticillata. A clear lens status and an otherwise quite anterior chamber were recorded. Fundus examination exhibited a bilateral optic disc edema with panretinal flame-shaped retinal hemorrhages, peripheral cotton wool spots and a macular edema with ring-shaped extra foveal hard exudates on the left side. (Figure 1 ) An Optical Coherence Tomography (OCT) examination (Heidelberg Spectral is; Heidelberg Engineering) exposed a leftsided cystoid macular edema ( Figure 2 ) and a right-sided regular foveal impression (not shown) besides bilateral parapapillary subretinal fluid accumulation. We were not able to perform a fundus angiography due to the terminal renal failure and the necessity to perform daily hemodialysis as well as the reduced general health of the patient.
We proposed the diagnosis of a right-sided partial and a left side complete Central Retinal Venous Occlusion (CRVO) and started a monthly intravitreal therapy regime with Bevacizumab (Avastin; Roche) in the left eye.
Ocular manifestations of Fabry disease are cornea verticillata, a whorl-like corneal pattern, cataract, as well as conjunctival and retinal vessel tortuositas. Retinal vascular tortuous it as is 
